Highlights from the J.P. Morgan Healthcare Conference 2016
Life science executives and investors descended upon San Francisco to share news and deal opportunities at the 34th annual J.P. Morgan Healthcare Conference, held January 11-14.
Here, DDDmag has rounded up some of the top news that came out of the conference.
1. Hope for gene therapy continues
2. Drug pricing dismissal
3. Digital health shines through
4. Pfizer, Allergan CEOs discuss proposed combination
5. Express Scripts stock plunges as client threatens to leave
6. GSK might consider spinoffs after Novartis deal
Read the full coverage at dddmag.com…





